Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$418.69 - $503.0 $2.09 Million - $2.52 Million
-5,000 Reduced 23.81%
16,000 $7.66 Million
Q4 2022

Feb 14, 2023

SELL
$351.71 - $456.01 $13.4 Million - $17.3 Million
-38,000 Reduced 64.41%
21,000 $8.83 Million
Q2 2022

Aug 15, 2022

BUY
$463.67 - $597.16 $8.81 Million - $11.3 Million
19,000 Added 47.5%
59,000 $29.2 Million
Q1 2022

May 16, 2022

BUY
$524.57 - $735.42 $21 Million - $29.4 Million
40,000 New
40,000 $22.5 Million
Q4 2020

Feb 16, 2021

SELL
$510.68 - $643.45 $20.4 Million - $25.7 Million
-40,000 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$454.43 - $535.6 $18.2 Million - $21.4 Million
-40,000 Reduced 50.0%
40,000 $20.6 Million
Q1 2020

May 15, 2020

BUY
$320.01 - $409.07 $25.6 Million - $32.7 Million
80,000 New
80,000 $28 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.37B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Tang Capital Management LLC Portfolio

Follow Tang Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tang Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tang Capital Management LLC with notifications on news.